QSM与R2* mapping定量评估子宫内膜异位卵巢囊肿铁沉积及卵巢功能可行性的研究
这项前瞻性研究纳入28例患者(33个病灶)病理确诊的子宫内膜异位卵巢囊肿,术前行含R2* mapping和QSM的MRI检查,并以电感耦合等离子体发射光谱法测定囊液铁浓度、血清抗苗勒管激素(AMH)评估卵巢储备。结果显示囊液铁浓度与R2*、QSM呈中度正相关,R2*与QSM高度相关;在<40岁组中AMH与铁浓度、R2*、QSM呈中度负相关,提示R2*与QSM可可靠定量囊肿内铁沉积,并与卵巢储备存在初步关联。
要点
- R2*与QSM高度相关(r=0.72,p<0.001),两者评估铁含量的一致性得到验证。
- 囊液铁浓度与R2*(r=0.55)、QSM(r=0.56)呈中度正相关,支持影像定量铁沉积的准确性。
- <40岁组AMH与QSM(r=-0.49)、R2*(r=-0.48)、铁浓度(r=-0.45)呈中度负相关。
核心结论
- R2* mapping与QSM可可靠定量子宫内膜异位卵巢囊肿内的铁沉积,体外验证支持其准确性。
- 铁沉积与卵巢储备之间的潜在关联提示这些方法在评估卵巢功能方面具有初步价值。
研究设计与样本
- 前瞻性研究,纳入28例患者共33个经组织病理学确诊的子宫内膜异位卵巢囊肿病灶。
- 术前MRI检查包含R2* mapping与QSM序列。
- 以电感耦合等离子体发射光谱法测定囊液铁浓度作为体外参考,以血清抗苗勒管激素(AMH)水平作为卵巢储备标志物。
- 采用Pearson相关与回归分析评估AMH、铁浓度、R2*与QSM值之间的关联。
关键影像表现/征象
- 子宫内膜异位卵巢囊肿囊液铁沉积可通过R2* mapping与QSM进行定量评估。
- R2*与QSM在评估铁含量时高度相关(r=0.72,p<0.001),两者一致性得到验证。
诊断标准与关键数值
- 全部年龄段组:AMH与年龄负相关(r=-0.74,p<0.001),与铁浓度负相关(r=-0.35,p=0.048)。
- 全部年龄段组:铁浓度与R2*正相关(r=0.55,p<0.001),与QSM正相关(r=0.56,p<0.001)。
- <40岁组:AMH与铁浓度负相关(r=-0.45,p=0.031),与R2*负相关(r=-0.48,p=0.019),与QSM负相关(r=-0.49,p=0.018)。
- 多元回归分析证实铁浓度、R2*、QSM是AMH水平的显著预测因子(p<0.05)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To evaluate the feasibility of quantitative susceptibility mapping (QSM) and R2* mapping in assessing iron deposition in endometriotic ovarian cysts (EMO) and their potential implications for ovarian reserve.
MATERIALS AND METHODS: This prospective study included 28 patients (33 lesions) with histopathologically confirmed EMO who underwent preoperative MRI examinations, including R2* mapping and QSM. Cyst fluid iron concentration ([Fe]) was measured via inductively coupled plasma optical emission spectrometry. Serum anti-Müllerian hormone (AMH) levels were quantified as a marker of ovarian reserve. Pearson correlation and regression analyses were performed to assess associations among AMH, [Fe], R2*, and QSM values.
RESULTS: In Group All Ages, AMH was negatively correlated with age (r = -0.74, p < 0.001) and [Fe] (r = -0.35, p = 0.048), while [Fe] showed moderate positive correlations with R2* (r = 0.55, p < 0.001) and QSM (r = 0.56, p < 0.001). In Group < 40 years, AMH exhibited moderate negative correlations with [Fe] (r = -0.45, p = 0.031), R2* (r = -0.48, p = 0.019), QSM (r = -0.49, p = 0.018). Multiple regression analyses confirmed that [Fe], R2*, QSM were significant predictors of AMH levels (p < 0.05). R2* and QSM were highly correlated (r = 0.72, p < 0.001), validating their consistency in assessing iron content.
CONCLUSION: R2* mapping and QSM reliably quantify iron deposition in EMO, with in vitro validation supporting their accuracy. Moreover, the potential link between iron deposition and ovarian reserve highlights the preliminary value of these methods in assessing ovarian function.
引用
- Ding D, Chang L, Wang X, et al. Feasibility study on QSM and R2* mapping for quantitative evaluation of iron deposition and ovarian function assessment in endometriotic ovarian cysts. Radiol Med. 2025. PMID: 41231331. doi:10.1007/s11547-025-02152-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。